GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

2月4日，默沙东突然宣布将暂停向中国供应HPV疫苗引起市场关注。公开资料显示， 默沙东将暂停向中国发货HPV疫苗Gardasil，预计至少持续到今年年中 。

对此，默沙东方面向澎湃新闻记者回应称，受整体市场环境、消费者需求疲软及渠道库存高等因素影响，默沙东与本土合作伙伴智飞生物进行了深入沟通，决定自2025年2月起根据消费者需求的动态变化，阶段性调整中国市场的发货节奏，预计将于年中逐步恢复常态。

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of foreign exchange, ...

to complete three doses of Gardasil-9. “In 2024, sales of out-of-pocket class II vaccines were impacted by macroeconomic pressures,” healthcare analysts at China Renaissance wrote last month ...

HPV infection is most commonly associated with cervical cancer, since roughly 99 per cent of all cervical cancer cases are connected to HPV. Nonetheless, experts warn that HPV is a virus that affects ...

Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a ...

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at least the middle of the year.

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...